Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoadjuvant Therapies × Immune Checkpoint Inhibitors × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 15 Carcinoma, Hepatocellular 9 Recurrence 5 Neoplasm Metastasis 5 Nasopharyngeal Carcinoma 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Stomach Neoplasms 4 Melanoma 4 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Neoplasms 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Small Cell Lung Carcinoma 2 Rectal Neoplasms 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer 2 Leukemia, Myeloid, Acute 2 Hyperthermia 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Biliary Tract Neoplasms 2 Advanced Refractory Solid Tumors 2 Advanced NSCLC 2

Interventions

Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07230639 2025-12-26

MODIFI-CC

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting

Neoadjuvant Therapies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡